Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

NCT04025879

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Local Institution - 0104 Tampa, Florida, United States
  • Local Institution - 0040 Atlanta, Georgia, United States
  • Local Institution - 0120 Augusta, Georgia, United States
  • Local Institution - 0145 Chicago, Illinois, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

NCT00977470

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Maryland Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

NCT04056247

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • Birmingham VAHCS Birmingham, Alabama, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Florida Cancer Specialist and Research Institute Orlando, Florida, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

NCT02767804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

NCT04035486

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Bellflower, California, United States
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Santa Monica, California, United States
View all 153 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

NCT04931654

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Fort Wayne, Indiana, United States
  • Research Site New York, United States
  • Research Site Nashville, Tennessee, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details

Related conditions